» Articles » PMID: 20214890

A Novel Yeast Cell-based Screen Identifies Flavone As a Tankyrase Inhibitor

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2010 Mar 11
PMID 20214890
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The telomere-associated protein tankyrase 1 is a poly(ADP-ribose) polymerase and is considered to be a promising target for cancer therapy, especially for BRCA-associated cancers. However, an efficient assay system for inhibitor screening has not been established, mainly due to the difficulty of efficient preparation of the enzyme and its substrate. Here, we report a cell-based assay system for detecting inhibitory activity against tankyrase 1. We found that overexpression of the human tankyrase 1 gene causes a growth defect in the fission yeast Schizosaccharomyces pombe. Chemicals that restore the growth defect phenotype can be identified as potential tankyrase 1 inhibitors. We performed a high-throughput screen using this system, and identified flavone as a compound that restores the growth of yeast cells overexpressing tankyrase 1. Indeed, flavone inhibited poly(ADP-ribosyl)ation of proteins caused by overexpression of tankyrase 1 in yeast cells. This system allows rapid identification of inhibitory activity against tankyrase 1 and is amenable to high-throughput screening using robotics.

Citing Articles

An "In Schizo" Evaluation System to Screen for Human Kinesin-5 Inhibitors.

Afdilla F, Hwang W, Yukawa M Methods Mol Biol. 2024; 2862:333-351.

PMID: 39527212 DOI: 10.1007/978-1-0716-4168-2_24.


A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.

Sato H, Murakami T, Matsuura R, Abe M, Matsuoka S, Yashiroda Y Viruses. 2022; 14(6).

PMID: 35746791 PMC: 9227106. DOI: 10.3390/v14061321.


3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.

Alam S, Khan F Sci Rep. 2019; 9(1):5414.

PMID: 30932078 PMC: 6443786. DOI: 10.1038/s41598-019-41984-7.


RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.

Mizutani A, Yashiroda Y, Muramatsu Y, Yoshida H, Chikada T, Tsumura T Cancer Sci. 2018; 109(12):4003-4014.

PMID: 30238564 PMC: 6272098. DOI: 10.1111/cas.13805.


Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.

Mariotti L, Pollock K, Guettler S Br J Pharmacol. 2017; 174(24):4611-4636.

PMID: 28910490 PMC: 5727255. DOI: 10.1111/bph.14038.